Portfolio (Quarterly)
Guide ↗
GordonMD Global Investments LP
· CIK 0002039349| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | KYTX | KYVERNA THERAPEUTICS INC | Healthcare | 4,244,818.0 | $36.6M | 25.51% | -147K | -3.4% | $8.63 | -21.1% |
| 2 | TSHA | TAYSHA GENE THERAPIES INC | Healthcare | 737,550.0 | $22.2M | 15.47% | -593K | -44.6% | $30.12 | -84.5% |
| 3 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 1,518,552.0 | $13.6M | 9.48% | +588K | +63.2% | $8.96 | +19.0% |
| 4 | BLCO | BAUSCH PLUS LOMB CORP | Healthcare | 573,472.0 | $9.1M | 6.35% | -40K | -6.5% | $15.90 | +6.0% |
| 5 | AMGN | AMGEN INC | Healthcare | 20,212.0 | $7.1M | 4.95% | -3K | -12.9% | $351.85 | +17.8% |
| 6 | SRRK | SCHOLAR ROCK HLDG CORP | Healthcare | 132,500.0 | $6.5M | 4.54% | NEW | — | $49.16 | -1.1% |
| 7 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 289,101.0 | $6.1M | 4.22% | -40K | -12.2% | $20.95 | -30.8% |
| 8 | PYXS | PYXIS ONCOLOGY INC | Healthcare | 4,121,870.0 | $6.0M | 4.19% | — | — | $1.46 | +95.9% |
| 9 | TEVA | TEVA PHARMACEUTICAL INDS LTD | Healthcare | 1,257,495.0 | $5.6M | 3.92% | +488K | +63.4% | $4.47 | +776.7% |
| 10 | SION | SIONNA THERAPEUTICS INC | Healthcare | 136,000.0 | $5.5M | 3.80% | NEW | — | $40.09 | -87.0% |
| 11 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 170,307.0 | $5.4M | 3.76% | — | — | $31.72 | -2.0% |
| 12 | INSM | INSMED INC | Healthcare | 28,587.0 | $4.7M | 3.25% | — | — | $163.52 | -27.9% |
| 13 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 126,985.0 | $4.6M | 3.21% | -97K | -43.3% | $36.32 | +133.9% |
| 14 | INCY | INCYTE CORP | Healthcare | 43,300.0 | $4.1M | 2.84% | -11K | -20.6% | $94.12 | +31.6% |
| 15 | ALLO | ALLOGENE THERAPEUTICS INC | Healthcare | 1,430,000.0 | $3.5M | 2.43% | NEW | — | $2.44 | -32.4% |
| 16 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 42,680.0 | $3.0M | 2.08% | -24K | -36.0% | $70.15 | +7.9% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%